human il 37 protein (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
human il 37 protein
Human Il 37 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 254 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+37/Recombinant+Human+IL-3+Protein/pmc12937001-104-2-11
Average 96 stars, based on 254 article reviews
Human Il 37 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 254 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+37/Recombinant+Human+IL-3+Protein/pmc12937001-104-2-11
Average 96 stars, based on 254 article reviews
human il 37 protein - by Bioz Stars,
2026-09
96/100 stars
Images
1) Product Images from "The diagnostic and immunomodulatory role of IL-37 in pediatric sepsis"
Article Title: The diagnostic and immunomodulatory role of IL-37 in pediatric sepsis
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2026.1765956
Figure Legend Snippet: Serum IL-37 levels on the day of admission were elevated in pediatric patients with sepsis. Serum IL-37 concentrations were quantified using ELISA in peripheral blood samples. (a) Cohorts Design: The study included a discovery cohort-Chongqing comprising healthy controls (n = 32), pediatric non-septic infection controls (n = 32), and pediatric sepsis patients (n = 40), as well as a validation cohort consisting of healthy controls (n = 48), pediatric non-septic infection controls (n = 40), and pediatric sepsis patients (n = 105). (b) In the discovery cohort (Chongqing), serum IL-37 concentrations were significantly higher in pediatric patients with sepsis. (c) In the validation cohort (Sichuan), serum IL-37 concentrations were also elevated in pediatric patients with sepsis. (d) In the discovery cohort (Chongqing), serum IL-37 levels in children with septic shock were higher than those in children with sepsis without shock. (e) In the validation cohort (Sichuan), serum IL-37 levels in children with septic shock were higher than those in children with sepsis without shock. Statistical significance was observed with *P<0.05; **P<0.01; ***P<0.001; and ****P<0.0001.
Techniques Used: Enzyme-linked Immunosorbent Assay, Infection, Biomarker Discovery
Figure Legend Snippet: The level of IL-37 in pediatric patients with bacterial sepsis. The pathogenic bacteria infected in patients with sepsis, (a) in the discovery cohort (Chongqing), (b) in the validation cohort (Sichuan). Serum concentrations of IL-37 in patients with sepsis associated with bacterial infections were measured (c) in the discovery cohort (Chongqing) and (e) in the validation cohort (Sichuan). The serum IL-37 concentrations were evaluated in cases of sepsis caused by Gram-positive and Gram-negative bacteria (d) in the discovery cohort (Chongqing) and (f) in the validation cohort (Sichuan).
Techniques Used: Bacteria, Infection, Biomarker Discovery
Figure Legend Snippet: The ROC curves for IL-37 at admission for the diagnosis of pediatric patients with sepsis. (a) The ROC curve for IL-37, IL-6, CRP, and PCT at admission in the discovery cohort, which included 40 pediatric patients with sepsis from Chongqing. (b) The ROC curve for IL-37, IL-6, CRP, and PCT at admission in the validation cohort, which comprised 105 pediatric patients with sepsis from Sichuan. (c) The ROC curve for IL-37 combined with PCT, CRP, and IL-6 in the discovery cohort from Chongqing. (d) The ROC curve for IL-37 combined with PCT, CRP, and IL-6 in the validation cohort from Sichuan. AUC refers to the area under the ROC curve; the cut-off value indicates the optimal diagnostic cutoff points for pediatric patients with sepsis; Sens (%): sensitivity; Spec (%): specificity; PPV(%): positive predictive value; NPV(%): negative predictive value.
Techniques Used: Biomarker Discovery, Diagnostic Assay
Figure Legend Snippet: The involvement of IL-37 in regulating inflammation during sepsis in vivo . (a) The flow chart detailing the animal experiments was provided. (b) A significant decrease in white blood cell (WBC) count was observed in the peritoneal lavage fluid (PLF) 24 hours after the administration of IL-37, in comparison to the control group treated with PBS and the control following cecal ligation and puncture (CLP). The concentrations of cytokines and chemokines in (c) blood and (d) PLF from septic mice (n = 5 per group), treated with either IL-37 or PBS 24 hours post-CLP, were quantified using ELISA. (e) mice (n = 8 per group) were injected intraperitoneally with rhIL-37 (2 μg/injection) at CLP, and survival was monitored for 7 days. The results for CXCL-1, IL-6, CCL2, and IL-10 in PLF were presented in a logarithmic scale. Statistical significance was observed with *P<0.05; **P<0.01.
Techniques Used: In Vivo, Comparison, Control, Ligation, Enzyme-linked Immunosorbent Assay, Injection
Figure Legend Snippet: The effects on macrophages and neutrophils in the peritoneal lavage fluid (PLF) 24 hours post-treatment with IL-37 or PBS in CLP mice (n=5 per group). Peritoneal macrophages were identified by gating on CD11b+F4/80+ cells. M1 macrophages in the abdominal cavity were identified by gating on F4/80+CD86+, while M2 macrophages were identified by gating on F4/80+CD206+. Peritoneal neutrophils were identified by gating on CD11b+Ly6G+ cells. (a) Shows the total number of macrophages in the PLF of CLP mice treated with IL-37–24 hours post-CLP. (b) Displays the number of F4/80+CD86+(M1) macrophages in the PLF of CLP mice treated with IL-37–24 hours post-CLP. *P < 0.05 indicates a significant difference when compared to septic mice treated with PBS control (Mann-Whitney U test). (c) Illustrates the number of F4/80+CD206+(M2) macrophages in the PLF of CLP mice treated with IL-37–24 hours post-CLP. (d) Depicts the number of neutrophils in the PLF of CLP mice treated with IL-37–24 hours post-CLP.
Techniques Used: Control, MANN-WHITNEY
Figure Legend Snippet: The concentrations of inflammatory cytokines IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ in the culture supernatant following treatment with IL-37 or PBS for 24 hours on PBMCs derived from pediatric patients with sepsis (n=4). The cytokines were quantified using the flow cytometry CBA method. a–f display the concentrations of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ, respectively, in the culture supernatant after treatment.
Techniques Used: Derivative Assay, Flow Cytometry
Figure Legend Snippet: The role of IL-37 in the immune regulation of sepsis in vitro . It presents the changes on lymphocyte subsets in pediatric sepsis patients following the administration with IL-37 in PBMCs. The parameters measured included: (a) the percentage of CD3+ T cells, (b) the percentage of CD4+ T cells, (c) the percentage of CD8+ T cells, (d) the CD4+/CD8+ ratio, (e) the percentage of CD3-CD19+ B cells, (f) the percentage of NK cells, and (g) the percentage of NKT cells. A statistically significant difference was observed with *P < 0.05 when compared to pediatric septic PBMCs treated with PBS control, as determined by the Mann-Whitney U test.
Techniques Used: In Vitro, Control, MANN-WHITNEY
Related Articles
Recombinant:Article Title: Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation. Article Snippet: IL-37, a newly found anti-inflammatory cytokine of the IL-1 family, has both extracellular and intracellular functions.. Accumulating evidences indicate that it is also involved in tumor progression.. However, the mechanism and its intracellular target are unclear. Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis. Article Snippet: .. OVA‐exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL‐37 group received 1 μg Article Title: The anti-inflammatory IL-37/SIGIRR axis is functionally compromised in HIV infection Article Snippet: .. Methods Reagents The reagents used in this study included Article Title: IL-37-induced activation of glycogen synthase kinase 3β promotes IL-1R8/Sigirr phosphorylation, internalization, and degradation in lung epithelial cells. Article Snippet: Funding information National Heart, Lung, and Blood Institute, Grant/Award Numbers: R01HL112791, R01HL131665, R01HL136294, R01HL151513; National of Institutes of Health, Grant/Award Number: R01GM115389 Abstract Interleukin (IL)‐37 diminishes a variety of inflammatory responses through ligation to its receptor IL‐1R8/Sigirr.. Sigirr is a Toll like receptor/IL‐1R family member.. We have shown that Sigirr is not stable in response to IL‐37 treatment. .. Article Title: Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells Article Snippet: Supernatants were then collected and analyzed using DuoSet ® human IL-37/IL-1F7 ELISA kits (R&D Systems, Minnneapolis, MN, USA) to measure IL-37 protein abundance, according to the manufacturer’s instructions. .. As controls, 1 and 2 ng/mL Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis Article Snippet: .. OVA-exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL-37 group received 1 μg Article Title: Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells. Article Snippet: Supernatants were then collected and analyzed using DuoSet® human IL-37/IL-1F7 ELISA kits (R&D Systems, Minnneapolis, MN, USA) to measure IL-37 protein abundance, according to the manufacturer’s instructions. .. As controls, 1 and 2 ng/mL Article Title: The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation Article Snippet: Human TLR4 stable transfected HEK293 (HEK293/TLR4) cells were from InvivoGen (San Diego, CA, USA). .. Saline:Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis. Article Snippet: .. OVA‐exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL‐37 group received 1 μg Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis Article Snippet: .. OVA-exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL-37 group received 1 μg Injection:Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis. Article Snippet: .. OVA‐exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL‐37 group received 1 μg Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis Article Snippet: .. OVA-exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL-37 group received 1 μg Sterility:Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis. Article Snippet: .. OVA‐exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL‐37 group received 1 μg Article Title: IL-37 relieves allergic inflammation by inhibiting the CCL11 signaling pathway in a mouse model of allergic rhinitis Article Snippet: .. OVA-exposed mice were randomly assigned to one of the following three groups (n=10 per group): The OVA group received no treatment; the OVA + Sal group received 1 μg saline by intraperitoneal injection prior to each OVA challenge and for 5 days between day 26 and day 30; and the OVA + IL-37 group received 1 μg Enzyme-linked Immunosorbent Assay:Article Title: Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells Article Snippet: Supernatants were then collected and analyzed using DuoSet ® human IL-37/IL-1F7 ELISA kits (R&D Systems, Minnneapolis, MN, USA) to measure IL-37 protein abundance, according to the manufacturer’s instructions. .. As controls, 1 and 2 ng/mL Article Title: Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells. Article Snippet: Supernatants were then collected and analyzed using DuoSet® human IL-37/IL-1F7 ELISA kits (R&D Systems, Minnneapolis, MN, USA) to measure IL-37 protein abundance, according to the manufacturer’s instructions. .. As controls, 1 and 2 ng/mL |